Product Images Clindamycin Phosphate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Clindamycin Phosphate NDC 0338-9545 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is an intravenous injection medication containing Clindamycin Phosphate in 0.9% Sodium Chloride. The concentration is 300mg/50mL (6mg/mL). This medication is not to be used with supplementary medication and should only be used for intravenous infusion. Caution is recommended when inspecting for minute leaks or solution clarity. Each 50 mL contains 450mg of sodium chloride, 2mg of edetate, and water for infection. Dosage information should be obtained from the prescribing information. The medication should be stored between 20°C to 25°C. This medication is available by prescription only. Baxter is a registered trademark of Baxter International Inc. Baxter Healthcare Corporation is located in Deerfield, IL USA.*
The text contains information about a product named "GALAXY Container PL2501 Plastic" that seems to have been registered under the trademark "Baxter". The text also mentions "Baxter Healthcare Corporation" located in Desreld, IL 60015 USA, and the information that it was made in the USA. Additionally, the text includes information about a product named "Clindamycin Phosphate in 0.9% Sodium Chloride Injection" that comes in 12-50 mL Single Dose Containers and requires storage at controlled room temperature. Overall, the text provides limited information and no clear description.*
This is a description for a medication called Clindamycin phosphate that is administered intravenously. It comes in a 50 L container and each one contains 300 mg of clindamycin phosphate with sodium chloride and other substances. It is only for IV use and should not be used in any other way. It is important to check for leaks and solution clarity. Dosage information is available in the prescribing information.*
This is a description of a pharmaceutical product labeled "Clindamycin Phosphate in 0.9% Sodium Chloride Injection". It contains 300mg of the active ingredient for every 50mL of the solution. The product code is 2G3455 and the NDC code is 0338-9545-24. The recommended storage temperature is between 20°C to 25°C and it is strictly for prescription use. The manufacturer/bottler's name is Baxter. It is advised to avoid storing the product above 30°C. The rest of the text seems to be a computer-generated code or serial number.*
This is a description of a medication called Clindamycin Phosphate, which is dissolved in 0.9% Sodium Chloride Injection. The medication is contained in a single-use container of 50 mL and is meant for intravenous infusion only. The cautionary information states not to add additional medications and to check for leaks and clarity of the solution. Each 50 mL dose contains 600 mg of Clindamycin Phosphate, 450 mg of Sodium Chloride, and other inactive ingredients. The medication should be stored at a temperature between 20°C to 25°C and discarded if not used. The manufacturer is Baxter Healthcare Corporation, and the medication is under the trade name of GALAXY.*
This is a description for a container labeled "GALAXY Container" with the registered trademarks of "Baxter" and "Galwy" of Baxter Healthcare Corporation in Desreld, Illinois. It is made of PL2501 Plastic and contains Clindamycin Phosphate in 0.9% Sodium Chloride Injection. The container holds 1250 ml as a single dose container that should be stored at a temperature between 20°C to 25°C (68°F or T7P) with controlled room temperature below 30°C.*
Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a medication with a strength of 600mg/50mL and the National Drug Code (NDC) is 0338-9549-24. It should be stored within the temperature range of 20°C to 25°C (68°F to 77°F), and temperatures above 30°C should be avoided. The medication is manufactured by Baxter. The rest of the text appears to be a code or batch number and manufacturing information.*
Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a sterile and non-pyrogenic solution used for intravenous infusion only. Each 50 mL of the solution contains 900 mg of Clindamycin phosphate, which is equivalent to 300 mg of Clindamycin, 450 mg of sodium chloride, USP 2 mg edetate of sodium hydrate, USP, and water for injection, USP. The pH of the solution may have been adjusted with sodium hydroxide and/or hydrochloric acid. It comes with a Galaxy container that has a code of 2G3457. The unused portion of the solution should be discarded. It is cautioned not to add supplementary medication and not to use it in series connections. Dosage information should be obtained from the prescribing information. The storage temperature should be between 20°C to 25°C (66°F to 77°F) and should be not be exposed to temperatures above 30°C. Baxter Healthcare Corporation, located in Deerfield, IL, is the manufacturer of the product.*
The text contains information about two products: GALAXY Container PL2501 Plastic, manufactured by Bader International Inc, and Clindamycin Phosphate in 0.9% Sodium Chloride Injection, containing 900mg per 50mL. The Clindamycin Phosphate Injection is stored at a temperature between 2°C to 25°C and comes in 12 to 50 mL single-dose containers. The GALAXY Container PL2501 Plastic has a registered trademark and is manufactured in the USA.*
This appears to be a medication label containing information such as the drug name, dosage, and cautionary statements. The medication is intended for intravenous infusion only and is sterile and nonpyrogenic. The dosage information is included, but caution is advised not to add any supplementary medication. The label also includes the drug's NDC and code numbers.*
Clindamycin Phosphate in 0.9% Sodium Chloride Injection is a prescribed medication available in a 50mL container with 900mg of clindamycin phosphate. The product code is 2G3457 and the NDC is 0338-9553-24. It should be stored at room temperature, between 20°C and 25°C (68°F to 77°F) and away from temperatures above 30°C. The medication is for medical use only and should be stored as per USP controlled room temperature guidelines. The excerpt also includes additional codes and references, but they don't provide further essential details about the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.